Douglas Logan
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Surgery 9
- Lipoproteins and Cardiovascular Health 7
- Pancreatic function and diabetes 2
-
- Diabetes Treatment and Management 5
- Diabetes Management and Research 4
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Co-authors
- Gary D. Swergold (3 shared papers)Neil Stahl (2 shared papers)Richard Wu (3 shared papers)Eleanor Lisbon (2 shared papers)George D. Yancopoulos (2 shared papers)Yunling Du (3 shared papers)Evan A. Stein (3 shared papers)Scott Mellis (3 shared papers)
- Journals
- Journal of the American College of Cardiology (6 papers)Diabetes Obesity and Metabolism (1 paper)Diabetes Care (1 paper)New England Journal of Medicine (1 paper)Journal of Diabetes and its Complications (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Douglas Logan
15 papers receiving 964 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Internal Medicine 84
- Endocrinology, Diabetes and Metabolism 252
- Cardiology and Cardiovascular Medicine 324
- Surgery 626
- Pharmacology 91
Countries citing papers authored by Douglas Logan
This map shows the geographic impact of Douglas Logan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Logan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Logan more than expected).
Fields of papers citing papers by Douglas Logan
This network shows the impact of papers produced by Douglas Logan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Logan. The network helps show where Douglas Logan may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Logan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol Hit paper breakdown → | 2012 | 505 |
| 2 | 2013 | 107 | |
| 3 | 2017 | 106 | |
| 4 | 2012 | 84 | |
| 5 | 2014 | 61 | |
| 6 | 2016 | 41 | |
| 7 | 2013 | 32 | |
| 8 | 2013 | 18 | |
| 9 | 2012 | 10 | |
| 10 | 1986 | 7 | |
| 11 | Abstract 16265: Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 With a Monoclonal Antibody REGN727/SAR236553, Effectively Reduces Low-Density-Lipoprotein Cholesterol, as Mono or Add-on Therapy in Heterozygous Familial and Non Familial Hypercholesterolemia | 2011 | 6 |
| 12 | 2014 | 6 | |
| 13 | 2011 | 5 | |
| 14 | 2012 | 3 | |
| 15 | 2014 | 1 |
About Douglas Logan
Douglas Logan is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 15 papers that have together received 992 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Pancreatic function and diabetes (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Pharmaceutical studies and practices (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Internal Medicine (84 citations), Endocrinology, Diabetes and Metabolism (252 citations), Cardiology and Cardiovascular Medicine (324 citations), Surgery (626 citations) and Pharmacology (91 citations). Douglas Logan has collaborated with scholars based in United States and Canada. Frequent co-authors include Gary D. Swergold, Neil Stahl, Richard Wu, Eleanor Lisbon, George D. Yancopoulos, Yunling Du, Evan A. Stein, Scott Mellis, María J. Gutiérrez and William Smith. Their work appears in journals such as Journal of the American College of Cardiology, Diabetes Obesity and Metabolism, Diabetes Care, New England Journal of Medicine and Journal of Diabetes and its Complications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.